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Trichohyalin  is an  intermediate filament-associated 
protein that associates in  regular arrays with  keratin 
intermediate  filaments (KIF) of the  inner root sheath 
cells of the  hair follicle and  the  granular  layer of the 
epidermis  and  is a known substrate of transglutami- 
nases. We have  determined the full-length sequence of 
human  trichohyalin  by use of RNA-mediated anchored 
polymerase chain  reaction methods and  from a genomic 
clone and  analyzed its potential  secondary  structure. 
We show here  that richohyalin may have at least three 
important  functions  in  these cells. The protein of 248 
kDa  is unusual in  that  it contains one of the  highest 
contents of charged  residues of any protein. Of several 
defined domains, domains 2-4, 6, and 8 are almost 
entirely a-helical, configured as a series of peptide 
repeats of varying  regularity,  and are thought to form 
a single-stranded  a-helical  rod stabilized by ionic in- 
teractions between successive turns of the  a-helix. Do- 
main 6 is  the most regular  and may bind KIF  directly 
by ionic interactions. Domains 6 and 7 are less well 
organized and may introduce folds in the molecule. 
Thus, human trichohyalin is predicted  to  be an elon- 
gated flexible rod at least 2 15 nm long and  to function 
as a KIF-associated protein by cross-linking  the  fila- 
ments in loose networks. In addition,  trichohyalin  is 
similar to, but several  times  longer  than,  involucrin, a 
known cell envelope constituent, so that together,  in- 
volucrin and  trichohyalin may serve as scaffold pro- 
teins  in  the  organization of the cell envelope of these 
cells or even anchor  the cell envelope to  the  KIF  net- 
work.  Finally,  trichohyalin possesses a pair of func- 
tional calcium-binding domains of the  EF-hand  type at 
its amino  terminus  that may be involved in  its calcium- 
dependent postsynthetic processing during terminal 
differentiation. 
One of the major differentiation  products of the  inner root 
sheath  and medullary cells of the developing hair follicle is 
large amorphous granules (1) composed primarily of the pro- 
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tein  trichohyalin  (TRHY)’ (2-5). Upon terminal differentia- 
tion  in  these tissues, the granules disperse, but the final fate 
and  structure of the protein  appear to be site-dependent. In 
the  inner root sheath,  the  TRHY protein becomes enmeshed 
with the keratin  intermediate  filaments  (KIF) of the cells (4, 
6,7) with an apparent periodicity of -200 nm (range of  100- 
400 nm) (8) or 400 nm (range of 200-500 nm) (9); in the 
medulla, the protein forms amorphous deposits that  are  not 
organized in any specific way  (2-4, 8). Furthermore, the 
protein undergoes a series of calcium-dependent postsynthetic 
enzymatic modifications. The TRHY  protein becomes  highly 
cross-linked to  KIF by  way of W-(y-glutamy1)lysine isodipep- 
tide cross-links formed by the action of transglutaminases of 
the hair follicle cells (6, 10, 11). In addition, many of the 
arginine residues are desimidated to citrullines by the action 
of the enzyme peptidylarginine deimidase (12-16).  However, 
the exact role and function of TRHY remain obscure. One 
line of reasoning suggests that  TRHY itself may  be converted 
from an amorphous to a filamentous protein since its desim- 
idation  appears to occur concurrently with the disappearance 
of the amorphous bodies and  the appearance of KIF  in  the 
inner root sheath (1-3, 8). Indeed, electron micrographs of 
partially extracted inner root sheath cells revealed tactoid- 
like TRHY molecules emerging from the granules into fila- 
ments (8). This concept would require that  the  TRHY protein 
contain the characteristic canonical a-helical  central rod do- 
main sequences of IF (17), but insufficient sequence infor- 
mation is available to resolve this issue. On the other hand, 
the protein may form a filamentous structure morphologically 
similar, but  not  structurally related, to  the  IF family. Never- 
theless, if the concept of an amorphous-to-filamentous protein 
transformation was correct, it does not explain why the med- 
ullary cells do not  contain significant numbers of filaments 
commensurate with the abundance of TRHY. An alternative 
possibility is based on the fact that  inner root sheath  (but  not 
medullary) cells do contain significant amounts of keratin 61 
keratin 16 KIF (18, 19). Thus,  TRHY may serve primarily as 
an intermediate filament-associated protein  (IFAP) (4, 9, 17) 
or matrix protein (20) in the inner root sheath cells by 
association with KIF  in  the regular arrays  as seen by electron 
microscopy and  later become cross-linked to them by isodi- 
peptide bonds. 
The abbreviations used are: TRHY, trichohyalin; KIF, keratin 
intermediate  filament(s); IF, intermediate  filament(s); IFAP, inter- 
mediate filament-associatedprotein; PCR, polymerase chain reaction; 
bp, base pair(s); kbp, kilobase pair(s); nt, nucleotide(s); CE, cornified 
cell envelope. 
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More recently, it  has become clear that  the expression of 
TRHY is not confined to the hair follicle. Good evidence 
exists showing that  it  is expressed in  the filiform papillae of 
dorsal tongue epithelium (9, 21, 22), a region that undergoes 
a course of "hard" keratin  differentiation  related to  that  in 
the hair follicle (23). In addition,  indirect immunofluorescence 
data indicate that  TRHY is also expressed in modest amounts 
in  the granular layer of newborn human foreskin epidermis 
(9, 21, 22), although its expression in interfollicular trunk 
epidermis is not yet clear (compare Ref. 5 with Refs. 21 and 
22). Thus, an important  question  arises  as to  its function in 
the epidermis. Does it also serve as  an IFAP for keratin 1/ 
keratin 10 KIF of the epidermis, or does it subserve another 
as yet unknown function? In addition, it  is  not known whether 
TRHY is subjected to  the same postsynthetic modifications 
seen in the hair follicle  cells. 
Current physicochemical data suggest that human, sheep, 
and pig TRHYs  are large proteins with apparent molecular 
masses of -200 kDa (5,9,22). For pig TRHY,  there is evidence 
for two components of -220 and 200 kDa (22). Shadowed 
electron micrographs of native pig tongue TRHY reveal an 
elongated particle of -85 nm with a  small bead on one end 
(22). The limited sequence information on sheep (5) and 
human (24) TRHYs reveals a  repeating peptide structure of 
a  potential @-helical conformation. 
In this paper, we describe the full-length sequence of human 
TRHY, deduced from the sequences of PCR-derived cDNA 
clones, and of a genomic clone. Analyses of its secondary 
structure suggest that  it adopts  a flexible single-stranded a- 
helical rod-like conformation, which is quite unlike an IF 
protein molecule. In  this way, TRHY is remarkably similar 
to,  but several times longer, than involucrin, a known protein 
constituent of the cornified cell envelope of the epidermis. 
However, unlike involucrin, TRHY possesses functional cal- 
cium-binding motifs of the  EF-hand type at its  amino  termi- 
nus. In  this way, TRHY is similar to profilaggrin, the precur- 
sor of a known interfilamentous  matrix  protein of the epider- 
mis. The potential significance of these several structural 
motifs suggests that TRHY may have multiple functions  in 
the epidermis and  hair follicle cells. 
MATERIALS AND  METHODS 
Procedures for Isolation and Sequencing of cDNA and Genomic 
Clones-A large portion of the cDNA sequences encoding human 
TRHY was determined by RNA-mediated anchored PCR (25) and 
characterization of the resulting sequence information. Aliquots of 
200  ng of DNase  I-treated total foreskin epidermal RNA (26) were 
reverse-transcribed at  70 "C with the series of (-)-strand primers (20 
pmol) listed in  Table 11. Following removal of the primer (Chroma 
spin 100 columns, Clontech), cDNAs thus produced were tailed in 
the presence of 200 p M  dCTP with 25 units of terminal  deoxytrans- 
ferase (GIBCO/BRL) for 1 h at 37 "C. PCR was then carried out with 
a commercial DNA amplification reagent kit (Perkin-Elmer Cetus 
Instruments) following the manufacturer's specifications, using 25 
pmol of an adaptor dG oligonucleotide as  the  (+)-primer  and 25 pmol 
of the specific primer (used in the cDNA synthesis step)  as  the (-)- 
primer. The conditions of PCR were as follows: 95 "C (5  min), 30 
cycles of denaturation at  95 "C (0.5 min), annealing at  42 'C (0.5 
min), and elongation at 72 "C (1.5 min). In some cases where the 
yield was low (due to difficulties of amplifying the multiple exact 
repeat regions), a  portion was then diluted 1:lOOO with buffer, and 1 
p1 was reamplified in a second round of PCR. The products were 
fractionated  on low-melting agarose gels, and  the largest fragments 
containing the most extended products were excised. Following pu- 
rification through Chroma spin columns, the  ends of the amplified 
cDNA were  filled in with Klenow DNA polymerase (27), subcloned 
into  the pGEM-3z vector (Promega Biotec), and  then sequenced by 
the didexoy chain  termination method with Sequenase Version 2.0 
(United States Biochemical Corp.). Following analysis ofthe sequence 
information, new primers with unique (nonrepeating) sequences were 
designed, and  this process was continued as far as possible in  a total 
of nine steps. Because of uncertainties regarding the location of the 
likely initiation codon and 5'-end of the mRNA, the 504-bp cDNA 
clone isolated previously (24) was used as a probe to screen a  human 
placental genomic DNA library (Clontech), from which a 14-kbp 
genomic clone, termed AH-TRHY-18, was isolated and plaque-puri- 
fied. Following Southern  blotting analyses, 6.5-kbp Sac1 and 8.0-kbp 
XhoI fragments  containing the  entire coding region of the gene  were 
cloned into pGEM-3z. Sequencing of these clones was done following 
the creation of a  nested set of deletion subclones using the Erase-a- 
Base kit system with the T7 and SP6 vector primers (Promega 
Biotec). 
Northern Blot  Analyses-Using established methods, total cellular 
RNA was prepared from human foreskins (26), newborn mouse 
epidermis (28), and human and mouse epidermal keratinocytes grown 
to confluency in the presence of a low (0.1 mM) or high  (0.6 mM) Ca2+ 
concentration (29, 30). Dr. Ulrike Lichti kindly provided a  prepara- 
tion of hair follicles purified from 5-day-old mice, from which  RNA 
was then prepared. Northern gels loaded with 25 pg of RNA were 
electrophoresed by established procedures (22) and calibrated with 
standard RNA size markers (GIBCO/BRL). Northern slot blotting 
was done as described (27). In  this case, the blots were calibrated 
with 0.01-10-fmol amounts of cloned probes for human (31) and 
mouse (32) keratin 10, human (33) and mouse (34) filaggrin, loricrin 
(35), and a 6.5-kbp human  TRHY genomic clone (described below). 
Slots of samples containing 10 pg of total cellular RNA were then 
tested with specific 3'-noncoding probes to each of the above. All 
Northern filters were washed with a  final stringency of 0.5 X SSC at 
65 "C for 30 min. The resulting  x-ray films were exposed for varying 
amounts of time to facilitate  quantitation of the abundance of the 
specific mRNA species by scanning densitometry. 
Protein Secondary Structure Analyses-Protein sequence homolo- 
gies and secondary structure predictions were performed using the 
amino acid sequence analysis program, University of Wisconsin Ge- 
netics Computer Group sequence analysis software packages (36), 
International BioTechnologies Inc. Pustell sequence software (Ver- 
sion 3.51, and Intelligenetics (Geneworks) software (37). Dot matrix 
comparisons were performed using the COMPARE and  DOTPLOT 
programs of the University of Wisconsin Genetics Computer Group 
running on the Massey University VAX or Geneworks (37). Fast 
Fourier transform analyses determining the periodic distributions of 
residues or residue types were carried out  as described by McLachlan 
and Stewart (38). General structural principles pertaining to oc-helix- 
rich proteins (39) were used in preliminary analyses. Numbers of 
potential intrachain ionic interactions between oppositely charged 
residues four positions apart (i.e. i -* i + 4) in a likely a-helical 
structure were calculated and placed on  a  per  heptad (7-residue) basis. 
These values, designated here as 14, allow direct comparisons with 
the interchain ionic interactions made between the chains of multis- 
tranded oc-fibrous proteins.  Such values typically lie in the range of 
0.2-0.8 (40). The ionic interactions are known to stabilize an a-helical 
structure  through  formation of salt links between residues on adjacent 
turns of the a-helix. 
In Vitro Calcium Binding Assays-This was done largely as de- 
scribed (41). An aliquot of 4 pg  of purified pig tongue TRHY (22) was 
resolved on  a 5-18% gradient polyacrylamide gel (42) and transferred 
onto  a polyvinylidine difluoride membrane (Immobilon P, Millipore) 
(43). A single membrane was used initially for determination of 
calcium binding and  then stained for protein and, after destaining, 
probed with an  anti-trichohyalin antibody (22). For calcium binding, 
the membrane was incubated for 1 h  in  10 JIM CaC12, 50 mM Tris- 
HCl (pH 7.5), 100 mM NaCl containing 10 pCi/ml 46CaC1z; washed 
twice in buffer without 45CaC1z; dried; and exposed to x-ray film. 
Quantitation of calcium binding activity was performed on  dot blots. 
Predetermined  amounts of the known calcium-binding proteins 
(mouse profilaggrin, human calmodulin, and human  troponin (posi- 
tive  controls)), the non-calcium-binding proteins (mouse keratin 10, 
mouse filaggrin, hen egg  lysoyme, and bovine serum albumin (negative 
controls)), and pig TRHY were spotted  on  a strip of polyvinylidine 
difluoride membrane and analyzed as described above. The autora- 
diographs were scanned and quantitated. 
RESULTS 
Northern Blot Analyses 
We have previously described the isolation and  character- 
ization of a 504-bp cDNA clone (24) obtained by PCR ampli- 
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fication of human genomic DNA using  primers based on the 
sequences encoding the carboxyl-terminal end of the available 
sheep TRHY sequence (5). This was used as a probe to 
estimate  the size, relative abundance, and expression charac- 
teristics of the human TRHY mRNA. On Northern gels, 
human  and mouse TRHY mRNAs are -6.7 kilobases in size 
(Fig. 1A). This  estimate is -10% larger than  that for sheep 
TRHY mRNA (5). In slot  blotting  assays, we estimated the 
abundance of human TRHY mRNA in  relation to a  number 
of major epidermal  mRNA species, including keratin 10, pro- 
filaggrin, and loricrin (Fig. 1B). Densitometric scanning re- 
vealed that  TRHY is <0.4 and <0.6% as  abundant  as  keratin 
10  and profilaggrin, respectively, in both  human  and mouse 
epidermides (Table  I). Since the  keratin 10 mRNA is thought 
to  constitute -25%  of epidermal  mRNA (28), this means that 
TRHY represents -0.1%  of total epidermal mRNA. While we 
have no  information  on the  rates of turnover  or  the fficiency 
of translation of the  TRHY mRNA, these  data nevertheless 
confirm the indirect immunofluorescence data (21) that 
TRHY protein is a  minor but significant  component of the 
terminal differentiation  pathway of human epidermis. Similar 
experiments (44) have revealed that  the mRNA for involucrin 
is about five times more abundant  than  that for TRHY.  In 
addition, the expression of TRHY mRNA is down-regulated 
in submerged liquid cultures of both mouse and  human epi- 
dermal cells grown in low calcium (0.1 mM) medium, and its 
expression is somewhat elevated by raising the calcium con- 
centration  to near  optimal levels (0.6 mM) (Fig. 1B  and  Table 
I) (29, 30). Thus,  the expression of TRHY mRNA is closely 
coordinated with that of other  late differentiation  products of 
the epidermis such as keratin 10, profilaggrin, and loricrin 
(Table  I) (28-30). Because we do not have a  calibration  probe 
of mouse TRHY,  the estimates for mouse tissues are only 
approximate. However, the level of expression of TRHY is 
elevated by a  factor of -25 in mouse hair follicles, as expected 
from its abundant expression in the developing inner root 
sheath  and medullary cells (1-4). Whereas the relative 
amounts of keratin 10, profilaggrin, loricrin, and  TRHY var- 
ied only -10% in  different preparations of human foreskin 
RNA (Table  I),  the much higher degree of variation of TRHY 
mRNA seen in different preparations of mouse epidermal 
cells (Table  I) may  be explained by the variable presence of 
developing hair follicle buds in  different  preparations of  new- 
born mouse epidermal cells (29). 
Deduced Amino Acid Sequence of Human TRHY 
We have used a  combination of two strategies to obtain the 
full-length coding sequence of human TRH. In the first, 
human TRHY-specific oligonucleotide primers  (Table 11) 
were constructed and used to prepare cDNAs by primer ex- 
tension. In  this way, it was possible to  "walk up most of the 
length of the mRNA (Fig. 2). Primer 9- extended only an 
additional 230 bp, suggesting that we had extended close to 
the 5'-end of the mRNA. The sequences of the oligo(dG)- 
tailed product of primer 9- included a potential initiation 
codon that conformed to a Kozak initiation site (44),  but we 
were uncertain whether this represented the  true initiation 
codon, largely because we found that these TRHY sequences 
shared a high degree of homology with those of the much 
more abundant profilaggrin mRNA (see Fig. 8). 
Accordingly, in the second approach,  a 504-bp cDNA  clone 
(24) was used to isolate a  14-kbp genomic clone, AH-TRHY- 
18. By Southern blotting  techniques using the aforementioned 
504 bp and several of the primer-extended cDNA clones 
described above, AH-TRHY-18 was found to  extend several 
kilobase pairs  upstream and  thus is likely to contain the entire 
coding region of human  TRHY (Fig. 2). Following subcloning, 
a 4.1-kbp portion overlapping the cDNA information was 
sequenced using  Erase-a-Base methods. Comparisons of the 
sequences of the available cDNA clones and AH-TRHY-18 
revealed the presence of two introns toward the 5'-end of the 
TRHY gene. One intron of 1275-bp splices sequences 54 bp 
and a second intron of 864-bp splices sequences 223 bp from 
the 5'-end of our cDNA sequence information. These  introns 
define an exon I of at  least 54 bp and  an exon I1 of 169  bp. 
Exon I1 contains the in-frame initiation codon described 
above (Figs. 2 and 3). Because we were unable to primer- 
extend the  TRHY mRNA sequences further, we conclude that 
FIG. 1. Northern blot analyses. A, 
Northern gel (25-pg load) probed with 
the 504-bp cDNA clone of one  batch of 
total cellular RNA from human foreskin 
epidermis (lane I ) ,  mouse epidermis 
(lane 2 ) ,  and mouse hair follicles (lane 
3). Migration  positions of size markers 
(GIBCO/BRL) are shown. B, slot blot 
estimating  the relative amounts of spe- 
cific epidermal  mRNAs in 10 pg of total 
cellular RNA from the sources shown. 
KlO, keratin 10; FIL, profilaggrin; LOR, 
loricrin; TRH, trichohyalin.  For quanti- 
tation purposes  (see Table I), the x-ray 
films were exposed for several different 
times  (4 h to 46 days);  this figure shows 
an exposure of 6 days. 
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TABLE I 
Abundances of selected mRNAs in mouse and  human epidermis and cultured cells 
The  data are the means f S.D. of four different  experiments, except for mouse hair follicles (one  batch, gift of Dr. Ulrike Lichti). These 
values were calculated from the  Northern slot blots (Fig. 1B) based on calibrations of 10, 1, 0.1, and 0.01 fmol of known cloned probes. 
Because we do not have a specific cloned probe of mouse TRHY,  the numbers  in  parentheses adduced here are based on the hybridization 
signal obtained with the human TRHY probe. 
Keratin 10 Profilaggrin  Loricrin  Trichohyalin 
Human foreskin epidermis 
Human, cultured, low Ca2+ 
Human,  cultured, high Ca2+ 
Mouse epidermis 
Mouse, cultured, low Ca2+ 
Mouse, cultured, high Ca2+ 
Mouse hair follicles 
63.5 f 5.5 
0.25 f 0.33 
1.75 f 0.24 
43.6 f 3.4 
0.23 f 0.33 
2.35 f 0.22 
0.47 
fmol/ZO p g  total cellular RNA 
42.3 f 3.7  39.4 f 3.8 
0.17 f 0.22  0.07 rt 0.11 
0.73 f 0.11 1.05 rt 0.17 
29.8 f 4.1  27.4 f 2.5 
0.11 f 0.13  .09 f 0.10 
0.28 f 0.19 
0.58 
0.16 f 0.09 
0.97 
0.28 f 0.03 
0.01 rt 0.02 
0.05 f 0.04 
(0.33 f 0.46) 
(0.00 f 0.02) 
(0.05 f 0.11) 
(8.85) 
TABLE I1 
Synthetic oligonucleotides used os primers for anchored PCR primer extension of human  TRHY mRNA 






















8067 to 8044 
7546 to 7569 
7569 to 7546 
6895 to 6871 
6211 to 6187 
5055 to 5035 
4580 to 4560 
4054 to 4029 
2742 to 2719 
2536 to 2513 
1 kbp 
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FIG. 2. Strategy map for  sequencing of human TRHY cDNA and genomic clones. The upper line designates the location of the 
genomic clone AH-TRHY-18 in relation to  the sequencing information. R, EcoRI; S, Sad; X ,  XhoI. The nested arrows denote sequences 
determined by deletion subcloning. The second l i n e  illustrates the  structure of the  TRHY gene. Exon I of 63 nt consists entirely of 5'- 
noncoding sequences; intron 1 is 1275 nt long; exon I1 of 169 nt  contains the likely initiation codon and encodes the first EF-hand motif; 
intron 2 is 864 nt long; and  the large exon 111 (6609 nt) consists of an additional 5553 nt of coding sequences and 1056 nt of 3'-noncoding 
sequences to  the polyadenylation signal sequence. The positions of the two EF-hand calcium-binding domains are shown (black boxes); the 
remainder of the coding sequences are also shown (dotted box). 5'- and 3"noncoding sequences are indicated (open boxes). The third line 
designates mRNA structure. Dashed lines connect the exon sequences to  the mRNA structure. Below this are shown the locations of the 504- 
bp cDNA clone isolated previously (24) and of the various cDNA clones constructed by primer extension and anchored PCR methods, Spots 
I +  and 1- denote the primers used to amplify the 504-bp cDNA clone (24); spots 2-, 3-, etc., refer to  the primers used for extension and 
PCR. The sequences and numbered locations of these  primers  are listed in  Table 11. 
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MCMGCCAmGTGGAGICAGAGGTGGAGCTGGGCTTGGTTAGG~GMTCAGGCC~TCCACAGAGTGGCTG 1 5  
potentla1 C U T  boxes 
TCTCCTTCCCMGTTGCTTTCCAGGCCACM~~CCCCT~~GGCCCAGCTCCCAGTTACCCAGTACAC 150 
POCCntlal TATA boxes likely capslte 










Intron 2 lsExs","6 P K T Y 0 L I I L 58 
tqc . f tq ta .aa t i t tC~CCrLCcaccaLr t ra t .qAGACCAC~TTGCCTMGA=GGTf f iATCTGATCC~GM 2550 
L L O R D S N G R Y D F N E F L L F I F ~ " ~ 0 ~  83  
CTTCTGGATCGTGACAGTMTGGGCGTGTCGATTTCMCGMTTCCTCCT~TTTA~TTTC~GTGCCTCMGCT 2625 
C Y Y A L G Q A T G L D E E K R A A C D G R E S L  108 
T G T T A C T I T G C T C T C G G C C A G G C C A C G G G A C T G G A T G I G G C C T G  2100 
L Q D R l r E e O Q R R F E P R O R O L E E E P G  1 3 3  
~ A C M G A T C G A C G G A C A C M C M G I C C ~ G G A G A T T C G ~ G C C C C G G G A C A G A C ~ C T G C M G M G M C C T G C G  2715 
Q R R R Q ~ R Q E O E R E L A E G E E Q S E I Q E  158 
C M C G A C G C A G G C A G M G A G G ~ ~ ~ G M C A G G I G I I C G O I G G  2850 
R L E Q R D R Q R R D E E L Y R Q R Q E W Q E R E  183 
CGACTTGMCffiCGCGACAGGCA=CGCCGCGACGAGGAGC=GTGGCGGC-GGCMGMTGGCMGMCGGGM 2925 
E R R A E E E O L Q S C K G H E T E E F P O E E P  208 
G A G C G C C G T G C A G l G G M G l G C A G C T G C A G ~ G ~ ~ G C I C M  3000 
L I I R E L L E L R R K G R E E K Q Q Q R R P R P  2 3 3  
C T G C G M G G C G G G A G C T G C T G G A G C T G A C G A G G G C C  3075 
D I V F O E E E E K E W R r R E T Y L R K E E E K  258 
GACAGIGTGTTCCIGG~GGMGMGAG~GAGTGGAGGMGCGCGAGAC~CTGC~CCGGMGGMGMGAGMG 3150 
L Q E E E P Q R O R E L P E E E E Q L R K L ~ R Q  283 
TTGCAGGMGAGGIGCCGCAGC~C-G*GAGCTCCAGG~GGMGMGAGCAGC=*CGCMCCTGGAGCGGCM 3225 
E L R R E R Q E E E O Q P Q R L R R L Q O L R I K  3 0 8  
GAGCTGAGGAGGGUICGCCIGGA~MGAGCAGCAGCAGC-GGCTGAGGCGCG~GCAGCMCTMGGCGCMG 3300 
O E E E R R E Q Q E E R R E Q Q E R R E Q Q E C R  333 
CAGGAGGAGGffiAGGCGCGAGCA~CAGGAGGAGAGGCGCGAGCAGCACG~GAGGCGCGAGCAGCAGGAGGAGACG 3375 
R E Q Q L R R E Q E E R R E Q Q L R R E Q E E E R  358  
CGCGIGCAGCAGCTGAGGCGCGIGCAGGAGGAG~GGCGCG~GCAGCAGCTG~GGCGCGAGCACGAGGAGGAGAGG 3450  
R E Q Q L R R E Q E E K R R E O Q L R R E P E E E  383 
CGCGAGCAGCAGCTGACGCGCC~CACGAGGAGGAGACGCGCGAGCAGCAGC~GAGGCGCGAGC~GGAGGAGGAG 3525 
R R E O Q L R R E O O l R R E Q Q L R R E O Q L R  108 
M~GCGCGMCAGCAGCTGAGGCGCCIGCAGCAGCTGAGGCGCGAGCAGC~GCTGAGGCGCCAGCAGCAGCTGAGG 3600 
R E O Q L R R E Q Q L R R E O Q L R R E P Q L R R  433 
CGCGAGCAGCAGCTGAGGCGG~CAGCAGCTGAGGCGCGAGCAGC~~~CTGAGGCGCGAGCAGCAGCTGAGGCGC 3675 
E Q Q L R R E O O L R R E Q E E E R H E P K H E O  458  
GAGC~AGCTGAGGCGCG~~~CAGCAGCTGAGGCGCGAGC~~~GAGGAGCAGAGGCACG~~~CAGMGCACGAGCAG 3750 
E R R E O R L K R E Q E E R R O W L K R E E E T B  4 8 3  
GAGAGGCGCGICCAGCGGCTGUGCOCGCG~GC*GGffiGAGAGGCGCG~TTGGCTGMGCGCGAGGffiGAGACGGAG 3825 
R H E Q E R R K Q Q L = R D O E E E R R E R W L K  508 
~C~CGIGCM~GAGAGGCGCI IGCIGCAGCTGMGCGCGACCA~~~AGGAGGIGAGGCGCGMCGTTGGCTGMG 3900 
L E E E E L R E Q Q L R R E Q P L R R E Q E E R R  533 
CTCGAGGAGGAGGAGAGGCGCGIGCAGUGGAGA~CGCGAGUGCMCTMGGC~GIGCMGAGGAGAGCCGC 3975 
E Q R L K R O E ~ C E R L O ~ R L R S E O O L R R  558 
G A G C A G C G G C T ~ C G C C I G G A ~ ~ ~ A ~ ~ ~ M G A G A ~ ~ ~ C T C C I G C A G C G G T T G A G G A G C G A G C M C M C T M G A C G C  1050 
E Q E E R L E Q L L K R E E E K R L E Q E R R E O  583 
GAGCAGGAGG~~~~~~GCTCGAGCAGCTGCTGMGCGCGAGGAGGAGMGAGGCTCGAGCAGGA~GCGA~CAG 4125 
R L K R E Q E E R R D Q L L K R E E E R R Q Q R L  608 
C G G C T G M G C G C G I G C I G G A G G ~ G C G C G A T C I G C T G C ~ G C G C G A f f i I G G I G A G G C G C C I G C ~ C ~ T G  4200 
~ R E Q E E R ~ E Q R L K R E E V E I L E Q E E R  633 
M G C G C G I G C ~ ~ ~ G M G A G I G C C ~ C G I G C I O C G A C T G M G  1 2 7 5  
R D E R L K R E E P E E E R R H E L L K S E E Q E  658 
C G C G I C G A G C G G C T G M G C G C G I G G I G C C G G A ~ G A G A G G C G C C ~ G A G C ~ C T G M G A G C G A C G A G C ~ A G  4350 
E R R H E O L R R E Q O E R R E O R L K R E E E E  6E3 
GAGffiGCGCCACGAGCMCTGAG~GCGAGUGCAGG~GGCGCGACCAGCGGCTGMGCGCGAffiAGGAGGM 1 4 2 5  
~ R L E O R L X R E B E E E R R E Q E L A E E E Q  708 
GAGIGGCTCGAGCAGCGGCTGMGCGCGAGCATGAGGMGIGAGGCGCGAGCAGGAGCTAGCTGIGGAGOIGCAG 4500 
E O A R E R I K S R I P K W Q W Q L E S E A D A R  733 
GMCAGGCCCGGG~~~CGGATTMGAGCCGCATCCCGMGTGGUGTGGCAGCTAG-GCGIGGCCGACGCAC~~~ 4575 
C-GC~GTCTTACTCGAGGCCCCGCMGCAGGUGCOGGCAGA~~~CGCCGCMG~GCAGGA~AGGCGG 4650  
Q S K V L L E A P P A G R A E A P Q E Q E E K R R  758 
R E S E L O Y g E E t R A H R g P Q E E E Q R R O  783 
CCCG~GIGTOAGCTGCMTGGCAGGAG~IGGMC~G~C=C~CC~GC~GC~GC~GGUGCOAGGIGCAGCGCCGGG~ 1125 
F T W Q W Q A E E ~ S E R G E Q R L S A R P P L R  808 
TTCACATGGCAGTGGCAGGCGGA~G~GAGCGAGAGGGGCCGTCAGAGGCTGTCGGCCAG~CCCCATTGCGG 4800 
E Q I E R Q L R A E E R O a R E Q R F L P E E E E  8 3 3  
GAGCAGCGGG~~~AGGCAGCTGAG=GCCGAGGAGCGCCAGCAGCGGGMCMCGGTTTCTCCCCGAGGAGGIGGAG 4875 
K E O R G R Q I R E R E K E L Q F L E E E E O L Q  850 
MGGAGCAGCGCGGCCGCCAGCGICCCGCGAG~GCGAC-GAGCTGCAGTTCCTGG*GGMGACGAGCAGCTCCAG 4950  
CTGT+TTMCTCTGCGTCMTCATMCMGATCTCATTGTCTCG-CTMCACMGTTCCCMTCACATMGGG 9225 
CATTTTGTTACTTATCTATGTCC-T~G-CAGGGGAGAGMTTC~GTTTTTCCCCMCCTT~TTT 9300 
T T T T T T R T T T T T T T T T T T T T G C A G T T A G G C T ~ M C T C T I I  9375 
TTTTTGTTCRGACCCACffiCTTTCTAT~CCITTCT~GCIGCGACTCACTGGTC~TG~C-~~=TCCTGCTCCC 9450  
M=ATTTGTTM=ATTTCCTTTIGIGUTGCIGCIGCTTC~TCGTC~CTGATGTC=GA~GAG=CMTG~.TAG~ 9525 A T ~ G C ~ T G ~ ~ C G T C ~ G A T C C T C G A C  9551  
FIG. 3 
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FIG. 4. Predicted secondary structure features of human TREY. Thia is set out in linear form for three  structural motifs based on 
Chou-Fasman (CF) ,  Robson-Garnier (RG) ,  or consensus (CfRg) analyses from the Wisconsin Genetics Computer Group package of analyses 
(36). The molecule is mostlv a-helical. configured in a series of long segments, interspersed with less regular regions matching the occasional 
proline residues; and  it contains  three’poteniial  sheet  structures. - 
the primer extension  experiments  had reached very close to 
the cap site for the TRHY mRNA. Indeed, searches for 
consensus sequences revealed a likely cap site just 9 bp 
upstream, at position 139 in Fig.  3. Potential TATA and CAT 
boxes reside 23-33 and -100 bp above this cap site. Thus,  the 
5’-end of the  TRHY gene is remarkably similar to  the  5’-end 
of the profilaggrin gene (46) and  to  the 5’-ends of several 
genes encoding small calcium-binding proteins of the SlOO 
family that contain EF-hand motifs (reviewed in Ref. 47). 
The  TRHY gene, like all of these  other genes, contains an 
exon I of  50-70 nt in  the 5’-noncoding sequences, an intron 
1 of  1-10 knt, an exon I1 of 150-170 nt containing the 
initiation codon and  the first  EF-hand motif, a  short  intron 
2, and  an exon I11 containing the second EF-hand motif and 
the remainder of the coding and 3”noncoding sequences. In 
the case of TRHY, exon I11 contains 6609 nt (to  a consensus 
polyadenylation signal sequence) including 5553 nt of coding 
and 1056 nt of 3”noncoding sequences. The human  TRHY 
mRNA is likely to be -6.9 kb in  length (including a poly(A) 
tail), in good agreement with the size estimate of 6.7 kbp 
estimated by Northern  blotting (Fig. L4).  
The nucleotide sequence from the likely initiation codon 
defines a single open reading coding frame of 5691 nt;  and 
thus, the deduced amino acid sequence of human TRHY 
contains 1897 amino acids (excluding the initiating methio- 
nine) with a calculated molecular mass of 248 kDa and PI of 
5.4 (Fig. 3). Thus, the molecular mass of human TRHY is 
-25 and 15% higher than  the masses determined by SDS- 
polyacrylamide gel electrophoresis for sheep (5) or pig (22, 
23) TRHY, respectively. The  net calculated p1 is lower than 
that predicted previously from histochemical staining  meth- 
ods for arginines (2, 3). Only  -3 of the 45 serines  and  threo- 
nines are potential targets for phosphorylation by known 
protein kinases, and none of the 8 asparagines are likely 
candidates for glycosylation. The human TRHY sequence 
contains an extraordinarily high number (59%) of charged 
residues (aspartic acid, glutamic acid, histidine, lysine, and 
arginine)  as well as many glutamines. Comparisons with the 
GenBank  and  NBRF data bases reveal that only one other 
described protein, involucrin, has  a  similar high content of 
charged residues (49%). TRHY  is  also homologous to mem- 
bers of the SlOO class of small calcium-binding proteins. 
Secondary Structure Features of Human Trichohyalin 
Secondary structure analyses suggest that -75%  of human 
TRHY will adopt an a-helical conformation. TWO pairs of 
short  a-helical segments are predicted to occur in the first 90 
residues, followed  by a series of a-helical segments of  50-600 
residues in  length that encompass all of the protein except 
for a  short  non-a-helical carboxyl-terminal domain -40-50 
residues long (Fig. 4). The a-helical segments are  interrupted 
by occasional short &turn sequences containing the proline 
residues (Fig. 4).  These  algorithms predict only small sections 
of sheet  structure  near  the amino terminus  and  three  other 
sections along the protein between residues 720 and 730, 780 
and 790, and 885 and 910, where an (apolar-polar)s-4 periodic- 
ity occurs. The presence of the high a-helical content is 
supported by direct physical measurement with circular di- 
chroism (Fig. 5). Although human  TRHY  has  not yet been 
isolated from any  tissue, it was recently shown that pig tongue 
TRHY  can be isolated in bulk under  nondenaturing condi- 
tions (22). Because of its similar size and biochemical and 
immunological properties (22), it is likely that  the amino acid 
sequence and predicted structure of pig TRHY is similar to 
those of human TRHY. Based on poly-L-lysine standards 
(47), the mean molar ellipticity value of -21,400 degrees. 
cm2/dmol suggests that pig TRHY  has  an  a-helical  content 
of 65-70% and a &sheet content of 10-15%, with 10-20% 
random coil. These values are in good agreement with the 
computer predictions of human  TRHY shown in Fig.  4. 
Analysis of the human TRHY sequence by dot  matrix  plots 
using the homology scoring system of Pearson  and Lipman 
(37) reveals the presence of several regions of peptide repeats 
(Fig. 6 and Table 111). These repeating regions are inter- 
spersed with regions of various lengths that lack the degree 
of regularity in the primary structure that is  characteristic of 
most of the molecule. These observations indicate that  the 
TRHY molecule consists of multiple domains, as  set  forth in 
detail below. Fast Fourier transform analyses (38) were thus 
used to evaluate these regions in detail, and  the results  are 
summarized in Table 111. Repeating peptide sequence motifs 
are shown. A model based on these analyses is shown in Fig. 
7. 
Domain 1 -The first 94 residues, which are predicted to be 
-50% &-helical, contain two calcium-binding domains of the 
EF-hand  type  that have 60-70% sequence homology in this 
FIG. 3. Nucleotide and predicted amino acid sequences of human TRHY. These data were accumulated from both the RNA- 
mediated anchored PCR cDNA clones and  the genomic clone AH-TRHY-18. The nucleotide sequence is numbered from the extent of our 
available sequence data above the likely CAAT box. Intron sequences are shown in lower-case letters. The likely CAAT, TATA, cap  site, 
initiation,  termination, and polyadenylation signal sequences are underlined. The single-letter code for amino acids is used, and residues are 
numbered from the codon following the initiation codon. Comparisons of the cDNA sequences and  the available genomic sequences revealed 
a number of polymorphisms. The genomic clone contained an additional glutamic acid at position 459 and a number of silent nucleotide 
substitutions at  codons 15 (AAT or AAC), 113 (CGC or CGG), 460 (AGA or AGG), 842  (CGG or CGC),  1024 (CGC or CGG), 1199 (TGC or 
TGT), 1361 (GAA  or GAG), 1362  (CAA or CAG), 1516  (GAG or GAA), 1559 (CTC  or  CTG), and 1766 (CTC  or  CTG). 
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region to members of the SlOO class of small calcium-binding 
proteins (47) and 70%  homology to human profilaggrin (Fig. 
8) (46). Each domain is composed  of an ordered series of polar 
residues that  are flanked by hydrophobic sequences and  that 
adopt the helix-turn-helix conformation required to bind a 
single ea2+ ion. The two EF-hand motifs are  separated  and 
immediately flanked by sequences that have not been well 
conserved between members of the  SI00 class of proteins. 
Domain 2-Residues 95-312 are predicted to be largely a- 
helical (>75%), but will suffer disruptions at  the 2 proline 
residues. There are no developed peptide repeats in this 
region. Nonetheless, charged residues of opposite sign fre- 
quently interface each other on alternate  turns of the  a-helix, 
thereby stabilizing a single-stranded a-helix through intra- 
chain ionic interactions of the type i + i + 4 (48). The 
remarkably high charged/apolar residue ratio of  4.4 and  the 
I4 value of  1.54 (Table 111) are suggestive of an elongated a- 
helical rod structure -32 nm long. 
Domain 3-Residues  313-443 can be subdivided into two 
sections, 313-389 and 390-443, on the basis of two well- 
developed types of repeats of 13  and 6 residues, respectively 
(Table 111). These  are predicted to be entirely a-helical; and 
again, adjacent turns of the a-helix are likely to be stabilized 
by favorable ionic interactions between interfaced oppositely 
charged residues. Thus, the high I4 value and the high 
charged/apolar residue ratio together favor the formation of 
an elongated a-helical rod structure -19 nm in length. 
Domain 4”Residues 444-702 consist of an irregular repeat 
dominated by numerous net deletions, but with a consensus 
repeat of 28 residues (Table 111). It is likely to be almost 
entirely  a-helical, although disrupted once by a single proline. 
It may possess additional flexible regions around multiple 
adjacent glutamines, tryptophans,  and/or  serines/threonines. 
The 14 value of 2.17 is  the highest in the  entire molecule, 
indicating the potential for a very stable  a-helical  structure 
also stabilized by intrachain ionic interactions on alternate 
turns of the a-helix. This rod-like domain would  be  -38 n m  
long. 
Domain 5-Although residues 703-922 are predicted to 
have a significant amount of a-helical structure, there are 
likely to be numerous breaks due to multiple prolines. Also, a 
semiconserved repeat  containing  a  characteristic  pair of tryp- 
tophans  (Table 111) is less clearly a-helical than most of this 
segment and may even favor the formation of intrachain or 
FIG. 5. TRHY is a highly  a-helical 
molecule as measured by circular di- 
chroism. Pig tongue TRHY prepared 
under  nondenaturing conditions was 
equilibrated into 20 mM sodium phos- 
phate  (pH 7.0) containing 1 M NaCl, and 
its circular dichroism spectrum was 









interchain  sheet  structures  about the (polar-apolar)s_4 envi- 
ronment. No other clear-cut repeat is evident, and the I4 
value of 1.05 is one of the lowest in the entire molecule. 
Because of the predicted turns  and  the tryptophan-rich quasi- 
repeats,  this region  may adopt  a more folded configuration of 
indeterminate  net length. 
Domain 6-Residues 923-1163 consist of eight almost per- 
fect repeats of  30 residues (as evident from the matrix plot in 
Fig. 6) that  are almost entirely a-helical, save for two potential 
kinks  around the prolines. The very  high I4 value of 2.03 and 
the charged/apolar residue ratio of 4.85 indicate a highly 
stabilized elongated rod structure of -36 nm, common in 
domains 2-4 described above. Interestingly, the 30-residue 
repeat also contains significant subrepeats  (Table 111), espe- 
cially one of 7.5 residues in length. This occurs for glutamic 
acid (scaled Fourier intensity of 43.61 and probability of 
occurring by chance of 1.1 X lo”’), leucine, and arginine 
(Table 111) and shows that  the  true period is approximately 
quartered. It also has the effect of placing an arginine or 
glutamate on almost every other  turn of one face of the a- 
helix. Since  this is slightly out of phase with 7.2 residues/two 
turns of an a-helix,  it will result in positively and negatively 
charged stripes winding around the axis of the a-helix with a 
pitch length of -14 nm. 
Domain 7-Residues 1164-1249 have similarities to those 
in domain 5 in that they  are predicted to have significant a- 
helical content, but are nonetheless likely to be folded, at 
least in part,  through the presence of predicted turns. Also 
present is a reasonably well-defined tryptophan-containing 
quasi-repeat previously noted in domain 5 .  There  are no other 
evident repeats, and  the relatively low I4 value of 0.73  may 
be insufficient to stabilize a single-stranded a-helix. A folded 
rather than extended conformation of indeterminate  net 
length may result. In contrast, however, the charged/apolar 
residue ratio is still high and is more compatible with a 
conformation with an appreciable axial ratio. Thus,  there is 
some difficulty is assigning a likely structure  to  this segment. 
Domain 8-Residues  1250-1849 consist of an almost unin- 
terrupted  stretch of a-helix configured as an irregular consen- 
sus 26-residue repeat (Table 111); many of the repeats are 
actually 24 residues long, and  about half are much shorter, 
containing only -16 residues. The sequence RQER- 
DRKFREEEQ is the common conserved element. Again, 
these repeats are characterized by long stretches in which 
Wavelength (nm) 
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FIG. 6. Dot  matrix profiie revealing that human TRHY was 
aseembled from multiple repeating peptide sequences. The 
homology scoring method of Ref. 37 was used with a window size of 
18 residues and a homology of 50%. Several major and some minor 
blocks of repeating sequences are  evident, suggesting that  the mole- 
cule was assembled during evolution from blocks of peptide repeats 
that were joined together by nonconserved sequences. 
oppositely charged residues would interface each other on 
alternate  turns of an a-helix.  Interestingly,  elements of a 7.7- 
7.9-residue repeat of very high probability are evident in 
glutamate and lysine + arginine residues (Table 111), sugges- 
tive of a  spiral of charged residues about the  a-helix of the 
general type described above for domain 6. The very high I4 
value of 1.86 and  the high charged/apolar residue ratio (3.72) 
favor the formation of an elongated single chain a-helical rod 
-90 nm in length. 
Domain 9-In residues 1850-1897, the carboxyl-terminal 
sequences are likely to adopt  a folded or random-coil confor- 
mation due to  the presence of prolines and glycines. Interest- 
ingly, the carboxyl-terminal 20 residues have been precisely 
conserved between sheep (5) and  human  TRHYs  and have 
afforded the manufacturing of a TRHY-specific antibody (22). 
The  net overall length of human TRHY is thus estimated 
to be at least 215 nm, arising from several distinct elongated 
rods. Domains 1 and 9 represent the globular amino- and 
carboxyl-terminal domains, respectively, whereas domains  5 
and 7 occur within the rod domain, but have an a-helix-rich 
structure of indeterminate  net  length. It is possible that  the 
human TRHY molecule in vitro (and possibly in vivo as well) 
folds about  domains  5  and  7  and forms a rod of  -100 nm with 
a knob of 15-20 nm (i.e. half of the length of domain 6) at 
the bend. This value compares with the -85-nm-long rod with 
a  12-nm bead on one end as visualized for  native pig TRHY 
by shadowing electron microscopy (22). Such a folded struc- 
ture, consisting of antiparallel  a-helices, conceivably could be 
stabilized by ionic interactions between the many charged 
residues along the equal-length domains 2-4 and 8. It remains 
unclear, however, whether  human  TRHY is folded in  half i n  
uiuo (as seen  in the in vitro preparations  studied by electron 
microscopy) or whether it is a single a-helix at least 215 nm 
long. 
Trichohyalin Is a Functional  Calcium-binding  Protein 
The sequence data of Fig. 3 and  the sequence homology 
data of Fig. 8 indicate the presence of two well-defined cal- 
cium-binding domains of the  EF-hand type. TO date, methods 
have not been described for the isolation of human epidermal 
or hair follicle TRHY. However, we show in Fig. 9A that pig 
tonme  TRHY is capable of binding 45Ca in vitro (lane 2) .  
Interestingly, unlike human TRHY, pig TRHY appears as 
two bands of -220 and 200 kDa (lune 1 ), both of which bind 
calcium (lune 2) .  In addition, a Western blot using a new 
TRHY antibody (22) raised against the carboxyl-terminal 18 
amino acids, which have been precisely conserved between 
human  and sheep TRHYs  and presumably in pig TRHY as 
well, also reveals two bands of the same sizes (lane 3). Since 
these data indicate that the amino- and carboxyl-terminal 
ends have been conserved, this means that pig TRHY is 
expressed as two distinct  protein products. By slot blotting 
(Fig. 9B) ,  we show that pig TRHY (-210 kDa, two EF-hands/ 
mol) binds 45CaC12 as effectively as calmodulin (14 kDa, four 
EF-hands/mol). As shown before (45), profilaggrin binds cal- 
cium somewhat more efficiently. Most of the calcium binding 
in  the  total epidermal extract is presumably due to  the profi- 
laggrin. 
DISCUSSION 
In this paper, we describe the likely full-length cDNA 
sequence of human  TRHY deduced from a series of cDNA 
clones generated by RNA-mediated anchored PCR  and from 
the genomic clone AH-TRHY-18. Northern  blotting  and slot 
blotting  techniques reveal that  its expression is regulated by 
calcium, and TRHY is thus a typical late differentiation 
product of the epidermis (Fig. 1). Analyses of its potenti $1 
secondary structure have revealed a wealth of new informa- 
tion  and clues to  its role(s)  in  differentiation  in the epidermis 
and derivative cell types. 
Human  Trichohyalin  Is a Long  Segmented  Rod-shaped Mol- 
ecule That Has the Potential  to  Interact  with  Keratin Znter- 
mediate Filaments-Human TRHY is unique in biology in 
that  it possesses the highest known content of charged resi- 
dues.  By use of secondary structure prediction and  fast Fourier 
transform analyses, we show that  it consists of nine well- 
defined domains. The bulk of the sequences, defined by do- 
mains 2-4, 6, and 8, are very highly charged, configured as  a 
series of peptide repeats of varying degrees of regularity that 
adopt an a-helical configuration. A point of great significance 
here  is that  the a-helix-rich segments do not have a  heptad 
substructure  characteristic of all  a-fibrous  proteins  that form 
a two- or three-stranded coiled-coil conformation (39). In 
each of the a-helical domains, there  are well-defined regular- 
ities  in the disposition of charged residues so that oppositely 
charged residues frequently lie on alternate  turns of the a- 
helix, thereby stabilizing the a-helix by intrachain ionic salt 
bonds. Indeed, the very high ratio of charged to apolar residues 
and  the number of intrachain ionic interactions/7 residues 
(I4 values; see Table 111) are  characteristic of a  stable single- 
stranded  a-helical configuration (38,47).  In  addition,  the v ry 
large numbers of polar glutamine residues are  to be expected 
to contribute  further to  this a-helical  structure by hydrogen 
bonding. Nevertheless, each of these domains is interrupted 
by an occasional proline residue, which is therefore likely to 
introduce bends or kinks along their length (Fig. 7). More 
important,  domains  5  and  7 have distinct and unusual fea- 
tures. While they still contain important elements of the 
other  domains with respect to high a-helix  content  and high 
charged/apolar residue ratios, they  are likely to adopt a more 
complex conformation due not only to  the presence of multiple 
prolines, but also to multiple tryptophans  and  other residues 
that favor the introduction of turns  and even limited sheet 
structures. Our preliminary conclusion is that these regions 
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TABLE I11 
Fast Fourier transforms of segments of the human TRHY sequence 




95-312  4.4  1.54 No organized repeating element; largely a-helical; 
ratio"  Comments 
Two well-defined EF-hand calcium-binding domains 
3  313-389 10.4  1.91 Repeat of 13 residues (RREQEEERREQQL) 
elongated rod, -32 nm 
390-443  3.0  1.02 Repeat of 6 residues (RREQQL); both form highly 
R 6.40 (12.8/2) 24.15 
Q 
E 
6.38 (12.8/2) 18.11 
12.64  (12.8/1)  7.88 
stabilized a-helix; elongated rod, -19 nm 
4 444-702  6.25  2.17 Irregular consensus repeat of 28 residues (LKRE- 
QEERREQRLKREEEEREQERREQR) or ((RE- 
QRLKRE(E/Q)EER),EQER)); highly stabilized a- 
helix; elongated flexible rod, -38 nm 
R + K 6.07 18.76 
R 6.08 14.60 
Q 6.08  8.19 
Q 5.90  9.36 
E 10.19 
5 703-922  2.62  1.05 
6 923-1163  4.85 2.03 










R 29.90  (30/1) 
E 7.52 (30/4) 
B 15.06 (30/2) 
7 1164/1249 3.15 0.73 
8 1250-1849 3.72 1.86 
L 7.85 
4.91 
R + K 7.89 





Potential regularity around W residues (QEQAR- 
ERIKSRIPWQWQLESEADAR); contains a-he- 
lix, but also several turns; potential for p-turns or 
even @-sheet; folded or globular 
Highly  regular 30-residue repeat (QEEEQLLREE- 
REKRRRQERERQYR(E/K)EEELQ); highly sta- 














No apparent regularity; contains a-helix, but also 
several turns; folded or globular 
Well-defined but irregular repeat with consensus of 
26 residues, but several are  shorter (RQERD- 
RKFREEEQQLRRQEREEQQLR) or ((EEQQL- 
RRQER)DRKFR.E)); most common element of 
RQERDRKFREEEQ; highly stabilized a-helix; 








Q 4.00 10.19 
9  1850-1897 No repeats; likely to be folded or globular due to 
frenmmt h ~ m e  
Charged/apolar ratio = DEKHR/LIVMFYA. 
' Number of possible intrachain ionic interactions  arising from residues four positions apart (48). The result (14) is presented here on  a 
per 7-residue basis for ease of comparison with the interchain ionic interactions that stabilized coiled-coil ropes in  a-fibrous  proteins (39,40). 
The higher the I4 value, the more stable is an a-helix. Typical values are  as follows: four (or more)-stranded  a-helical bundle, charged/apolar 
residue ratio of <0.5 and I4 - 0; three-stranded a-helical coiled coil, charged/apolar residue ratio of -0.8 and I4 = 0.5; two-stranded  a-helical 
coiled  coil, charged/apolar residue ratio of -1.0 and I4 = 0.8; and overall charged/apolar residue ratio of TRHY of 4.1 and I4 = 1.7. This 
supports  the idea that  TRHY forms  a  single-stranded  a-helical rod stabilized by ionic salt bridges between oppositely charged residues that 
lie four positions apart on adjacent turns of the a-helix. 
The major scaled intensities >9 corresponding to periodicities >4 residues are given. The probability of intensity ( I )  occurring by chance 
is exp(-I). 
may promote folds in  the human  TRHY  structure. Domains bonds across the two arms of the molecule. This would create 
2-4 (total length of -89 nm)  and 8 (length of -90 nm) could a molecule -100 nm long with a knob of 15-20 nm comprising 
conceivably fold back on each other, hinged about  domains 5 domains 5-7. Interestingly,  this model is generally consistent 
and 7 and stabilized by the potential to form many ionic salt with existing data. Native pig TRHY is -85-90 nm long and 
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NHZ- w I IWI I - COZH 
Domain 
Number 1 2 3 4  5 6 7  8 9 
Approximate 
Length ( n m )  ? 32 18.5 28 ? 36 ? 90 ? (2215)  
FIG. 7. Model  of structure of human TRHY. We propose that  the molecule consists of nine domains. Domain 1 (shown as a circle) 
contains two EF-hand calcium-binding domains. Domains 2-4 are largely a-helical and  are delineated by varying peptide repeats (see Table 
HI). Domain 5 contains several short  and one longer stretch of a-helix interspersed with turn, coil, or possibly sheet regions. Domain 6 also 
adopts an elongated configuration and constitutes the most regular portion of the molecule, to which KIF may associate through periodic 
ionic interactions. Domain 7 is also likely to be folded. The long domain 8 consists of peptide repeats that adopt an elongated a-helical 
configuration. Domain 9 contains the carboxyl terminus,  apparently conserved among TRHY molecules of different species. The lengths of 
the more regular domains are shown. The  net length  contributions of domains 1,5,7,  and 9 are  not known. It is possible that human TRHY 
either ( a )  folds in half around  domains 5 and 7, so as  to produce an elongated configuration -100 nm long with a large bead 15-20 nm in 
diameter corresponding to domain 6; or ( b )  remains extended and is >215 nm. 
1 """"_ """""""""""- """""""""- helix turn helix 
Trichohyalin S P L L R S I C D I T E I F N Q Y V S H D C D G A A L T K K D L K N L L E R E F G A V L R  
Profiiaqqrin S T L L V F I F A i i N L F N E Y S K K D K N ? D T L S K K E L K E L L E K E F R Q I L K  451 
slooa S E L E K A M V A L I D V F H Q Y S G R E G D K H K L K K S E L K E L I N N E L S H F L E  
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pii S Q M E H A M E T M M F T F H K F A - " G D K G Y L T K R D L R V L M E K E F P G F L E  
Calcyclin C P L D Q A I G L L V A I F H K Y S G R E G D K H T L S K K E L K E L I Q K E L T S I - G  
C y s : i C f i b r o s i s T E i E K A L N S I I D V Y H K Y S L l K G N F H A V Y R D D L K K i L E T E C P Q Y I R  
helix 
46 """"_ """""""""""- """""""_ t u r n  helix 90 
Trichohyalin R P H D P K T V D L I L E L L D R D S N G R V D F N E F L L F I F F V A Q A C Y Y A L G Q  
Profilaqqrin N P D D P D M V D V F ! 3 D H L D i D H N K X i > ? T E F L L M V F K L A Q A Y Y E S T R K  
slooa E I K E Q E V V D K V M E T L D N 3 G D G E C D F Q E F " V T T A C H E F F E I ?  
SlOOP S G K D K D A V D K L L K D L D A N G D A Q V D F S E F I V F V A A I T S A C H K Y F E K  
PI1 N Q K D P L A V D K I M K D L D Q C R D G K V G F Q S F F S L I A G L T I A C N D Y F V V  
Calcyclln K L Q D A E 1 A R L M : F D L D R N K D G E V N F Q E Y V T F L G A L A L I Y N E A L K G  
C y s t l c f i b r o s i s K K G - - - - A D V W F K E L D I N T D G A V N F Q E F L I L V l K M G V A A H K K S H E  
FIG. 8. Alignment of human TRHY and selection of human S100-like calcium-binding proteins  that contain  two homologous 
EF-hand motifs. The arrow after residue 45 delineates the point a t  which intron 2 splices coding sequences between the two EF-hand 
motifs. The helix-turn-helix sequences that define each motif are shown. Relative amino acid deletions are denoted by dashes. Sources are as 
follows: trichohyalin, Fig. 3 of this work; profilaggrin, Ref. 46; S100a, p l l ,  calcyclin, and cystic fibrosis antigen, Ref. 47; and SlOOP, Ref. 49. 
FIG. 9. TRHY is a  functional  cal- 
cium-binding protein. A, separation 
by polyacrylamide gel electrophoresis of 
pig TRHY reveals two bands of -220 
and 200 kDa (22) that can be stained 
with Coomassie Blue ( l a n e  I )  and  that 
can also be detected by  "Ca binding 
( l a n e  2) or by use of a specific carboxyl- 
terminal epitope antibody ( l a n e  3). B, 
dot blots quantitating 'Ta binding. The 
indicated proteins (1-10 pg)  were applied 
and incubated with '6CaC12 as described 
under  "Materials and Methods." The 
first column of numbers describes a 
quantitative value determined by scan- 
ning densitometry. In the second col- 
umn, these values have been scaled in 
relation to calmodulin (1.00) as '%a 
binding/mole. Thus, despite their large 
relative sizes, pig TRHY  and mouse pro- 
filaggrin are very efficient calcium-bind- 
ing proteins. It has not been possible to 
isolate TRHY from total foreskin epi- 
dermal extracts, but the '5Ca incorpo- 
rated  in such an extract is largely due to 
the presence of profilaggrin (46). 
A. GEL B. DOT BLOTS WITH 45CaC12 
ELECTROPHORESIS 
Sample  Relative Molar 
1 2 3  
possesses a 12-15-nm bead on  one  end (22). Pig  TRHY is 
-15% smaller than  human  TRHY,  but possesses functional 
calcium-binding domains (Fig. 9) and a conserved carboxyl- 
terminal domain 9 (see above and Ref. 22). Future work will 
show whether the size difference between pig and human 
incorporation ratio 
total mouse epidermal extract 
mouse filaggrin 
mouse profilaggrin 




bovine serum albumin 
hen egg lysozyme 
432 
0 0 
276  1.35 
0 0 





TRHYs is due to a net deletion in sequences corresponding 
to domains 5-7. 
However, it is quite possible that this apparent folded 
conformation  seen  in the electron microscope  is a technical 
artifact. Not surprising because of its very high charge, pig 
12174 Structure of Human Trichohyalin 
TRHY is soluble only in 1 M salt solutions (22). Thus, 
following  removal of the  salt  into glycerol during application 
to a grid for shadowing, it is probable that  TRHY folds in 
half, induced by ionic interactions of the very highly charged 
properties of the protein. 
Our calculations show that unfolded human  TRHY is at 
least 215 nm long in toto and perhaps as much as 260 nm 
(including length contributions of domains 5  and 7, but  not 
of domains 1 and 9). Interestingly,  this length is  the same as 
the range of the periodicities of interaction of TRHY with 
KIF in inner root sheath cells (8, 9). Thus,  it is possible that 
TRHY constitutes an elongated, somewhat flexible cross- 
linking  IFAP  in  these cells. 
Based on these analyses, it is clear that  the likely secondary 
structure of human TRH is different from that of an IF chain. 
Such proteins  are characterized by a well-defined central a -  
helical rod domain, the sequences of which form a two-chain 
segmented coiled-coil motif (17, 40). Accordingly, an earlier 
hypothesis that suggested that  TRHY is the precursor of the 
IF-like filaments of the  inner root sheath cells (1-3, 7) is no 
longer tenable. 
Of the a-helical domain segments, domain 6 is the most 
regular, with eight near-exact 30-residue repeats (see Fig. 6); 
but  it nonetheless possesses unusual features. The glutamic 
acid, arginine, and leucine residues are each configured as  a 
quasi-repeat of -7.5 residues (i.e. 30/4) (Table 111), corre- 
sponding to slightly more than two turns of the a-helix (3.6 
residues/turn). A similar repeat is also evident to some extent 
in domain 8. Thus, while many of the positive and negative 
charges will form stable ionic interactions, the  net result will 
be a slow spiral of charged residues around the axis of the a- 
helix. While the pitch length of this spiral is critically de- 
pendent on the number of residues/turn in the a-helix, a 
length of  14 nm seems likely. Now, the rod domain 1B  and  2 
segments of intermediate  filament  chains possess a 9.8-resi- 
due periodicity in  the linear  distributions of charged residues 
(17, 40). This is equivalent to a  linear rise of the coiled  coil of 
-1.4 nm, or one-tenth of the periodicity of domain 6. Accord- 
ingly,  by formation of periodic ionic interactions of the 
charged residues on the IF rod domain segments with the 
highly ordered domain 6 (and perhaps also with domain 8),  it 
is possible that human  TRHY could function as  an  IFAP  in 
the epidermis and  inner root sheath cells. 
Human  TRHY  has 332 glutamine and 104 lysine residues, 
which are  potential  targets for cross-linking by transglutam- 
inases. Earlier peptide sequencing data suggested the presence 
of numerous isodipeptide cross-links in both  inner  root  sheath 
and medulla proteins (6, 11, 12). In the case of the  inner root 
sheath, many of these involved the non-a-helical  end domain 
sequences of KIF of the cells, perhaps because of accessibility 
(6),  and  are likely to involve interchain  links between TRHY 
and KIF. However, we cannot predict whether additional 
intrachain or interchain cross-links involve only TRHY,  or 
other molecules. In addition, it is not evident from these 
structural considerations or the available sequencing infor- 
mation which domain(s) of the  TRHY molecule are involved 
in cross-links. 
Early amino acid composition and sequencing data showed 
that in the mature inner root sheath  and medulla proteins 
of the guinea pig hair follicle, -25 and 40-50%, respectively, 
of the arginines are converted to citrullines by desimidation 
(10-12). We estimate that conversion of  200 or more arginines 
to citrullines will lower the PI of the  intact human  TRHY 
protein to -4. Similarly, a significant, although unknown 
number of lysines will be effectively discharged by the for- 
mation of the isodipeptide cross-links. Since the arginines 
and lysines lie on the periphery of the a-helix,  they will be 
readily accessible by peptidylarginine desimidase and  trans- 
ghtaminase(s). More important, however, this discharging of 
many basic residues will likely interfere significantly with the 
formation of ionic salt bonds responsible for stabilizing the 
single-stranded a-helix. Conversion of  200 arginines will  lower 
the charged/apolar residue ratio  substantially, effectively de- 
stabilizing the structure. Accordingly, we predict that  TRHY 
becomes a much less regularly organized molecule upon post- 
synthetic modification. Perhaps  this is important if a princi- 
pal function of TRHY as an IFAP in the hair follicle and 
epidermal cells is to cross-link KIF. 
Human Trichohyalin Shares Significant Structural  Similar- 
ities with Cell Envelope Protein Involucrin-During terminal 
stages of differentiation  in the epidermis, the cells acquire a 
dense layer of protein on the intracellular side of the plasma 
membrane, termed the cornified cell envelope (CE) (50, 51). 
This  structure is assembled from a series of precursor mole- 
cules, including loricrin (35), involucrin (52),  cystatin A (53), 
proline/lysine-rich proteins (54), and perhaps other minor 
constituents that have not yet been well characterized (51, 
55, 56). These form a highly insoluble protein  barrier due to 
cross-linking by multiple epidermal transglutaminases that 
catalyze the formation of W-(y-glutamy1)lysine isodipeptide 
bonds (50, 51). Amino acid analysis (44) and immunohisto- 
chemical studies at  the electron microscope level (57) have 
suggested a model in which one or more of the soluble pre- 
cursors (involucrin, cystatin A) are deposited initially to  pro- 
vide a “scaffold,” to which loricrin is subsequently deposited 
in large amounts  as the CE is formed during  terminal stages 
of differentiation (57). Recently, a  structural model  was pro- 
posed for involucrin (58). It is composed largely of peptide 
repeats with a regular array of polar and charged residues 
similar to those for TRHY, with the predominant repeating 
element of 10 residues. In  this way, charged residues would 
also lie on  the periphery of the a-helix, capable of forming 
stable ionic salt bonds between adjacent turns (48, 58). Ac- 
cordingly, it was predicted that involucrin adopts an elongated 
(46-nm-long) single-stranded a-helical flexible rod-like struc- 
ture,  thereby fulfilling the requirements of a scaffold protein 
(58). 
We have documented in  this paper that human  TRHY also 
consists largely of peptide repeats that possess similar perio- 
dicities in charged residues and forms an elongated single- 
stranded a-helical flexible configuration (Fig. 7 and Table 
111). Indeed, searches in  GenBank  and  NBRF files reveal that 
human  TRHY peptide repeating domains 2-8 share signifi- 
cant sequence homology with only involucrin. Our model for 
TRHY differs from that described for involucrin primarily in 
that  it is several times longer. Since, as discussed, TRHY of 
the  inner root sheath  and medulla cells is a major substrate 
for transglutaminases,  TRHY expressed in the epidermis may 
serve as a substrate as well. Accordingly, in view of these 
remarkable similarities, we suggest that  TRHY may also serve 
as  a scaffold protein within the CE, perhaps  during  a  later 
stage of assembly or stabilization, commensurate with its later 
stage of expression in the epidermis (Fig. 1) (28-30). 
Trichohyalin Is a Functionul Calcium-binding Protein-The 
amino acid sequence information has revealed the  surprising 
finding of a  pair of calcium-binding domains of the  EF-hand 
type, typically found  in small S100-like calcium-binding pro- 
teins (Figs. 3, 8,  and 9) (47). TRHY  and  the SlOO proteins 
share significant homology with each other at  the level of 
gene structure.  Their  transcribed sequences consist of three 
exons, the first of which consists of 5”noncoding sequences, 
the second of which contains the initiation codon and the 
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first EF-hand motif, and the third of which contains the 
second EF-hand motif as well as  the remainder of the coding 
sequences. Moreover, the locations of the  exonlintron bound- 
aries of human TRHY and the SlOO proteins have been 
precisely conserved. In addition, we (46) have recently discov- 
ered that human profilaggrin also contains two EF-hand 
motifs at its amino terminus  that  are organized at  the protein 
and gene  levels in  a  fashion  identical to  that of the SlOO class 
and of the human  TRHY gene adduced here. The experiments 
of  Fig. 9 in  this  paper for pig TRHY  and for human profilag- 
grin in Ref. 46 have revealed that these  EF-hand  motifs in 
the two proteins  are in fact  functional  in binding calcium in 
vitro. Logically, therefore, it seems likely that TRHY is a 
functional Ca2+-binding protein  in vivo. 
The most notable differences between TRHY  and  the SlOO 
class of proteins  are the size and  nature of the amino acid 
sequences beyond the  EF-hand motifs. Most members of the 
SlOO class of proteins possess only short sequences flanking 
the second EF-hand motif and share little overt sequence 
homology with one another (47). These sequences are  thought 
to be involved in Ca2+-mediated interactions with different 
target effector molecules (47). In  contrast,  the human  TRHY 
sequences extend for more than 1700 residues, largely confi- 
gured in a series of quasi-repeating peptides. Moreover, as 
discussed, these sequences are subjected to  at least two differ- 
ent types of postsynthetic modifications that are calcium- 
dependent. Certain lysine donor and/or glutamine acceptor 
residues become involved in the formation of "(y-glu- 
tamy1)lysine isodipeptide cross-links catalyzed by transglu- 
taminases (6, 10, ll), and many arginines are converted to 
citrullines by the enzyme peptidylarginine deimidase (12-16). 
It is therefore entirely possible that the calcium binding 
properties of the  EF-hand motifs are involved in  these  post- 
translational reactions. Further work  will  be necessary to  test 
this hypothesis. 
We have shown by use of human-rodent hybrid cell lines 
and fluorescent in  situ hybridization that  the human  TRHY 
gene is located at chromosome region lq21.1 (24), within -1.8 
Mbp (59) of the other epidermally expressed genes, loricrin 
(60), profilaggrin (33), and involucrin (52). Each of these 
proteins, like TRHY, consists largely of a series of quasi- 
repeating peptides. In addition, the genes of some of the 
members of the SlOO class also map to  this region (61, 62), at 
least one of which, calcyclin, is known to be expressed in the 
epidermis (62, 63). Thus,  it seems possible that  the  TRHY 
and profilaggrin genes arose during evolution by fusion of an 
ancestral gene containing multiple peptide repeats with an 
ancestral gene containing the EF-hand-like calcium-binding 
motifs and were subsequently retained at chromosome region 
lq21.1. 
Is Trichohyalin a Multifunctional CE, IFAP,  and Calcium- 
binding Protein?-Characterization of the likely structural 
properties of human  TRHY have allowed us to identify three 
major potential  functional properties: the potential binding 
sites by ionic interactions with KIF so as  to serve as  an IFAP, 
in accordance with available morphological and antibody dec- 
oration studies; the potential role  of the  EF-hand motifs in 
the regulation of the  post-translational modifications of 
TRHY during  terminal  differentiation;  and the potential role 
of TRHY in CE formation or assembly due to its remarkable 
structural similarity to  the known CE scaffold protein invol- 
ucrin. Indeed, we suggest that  TRHY may serve as  a cross- 
bridge between the CE and  KIF network to afford flexible 
structural integrity to the tissue. In the hard keratinizing 
tissues such as  the  inner root  sheath  and tongue epithelium, 
where a more  rigid structure is required, TRHY is expressed 
in large amounts;  in the epidermis, where more flexibility is 
required, TRHY is expressed in lesser amounts. Further work 
will now be directed toward testing each of these  potential 
functions by use of transgenic technology with our genomic 
clone and by expression of various domain-specific portions 
of the TRHY molecule identified here for use in in vivo 
transfection and in vitro structure-function assays. 
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